A Helicopter Perspective on TB Biomarkers: Pathway and Process Based Analysis of Gene Expression Data Provides New Insight into TB Pathogenesis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Joosten, Simone A ^a   Fletcher, Helen A ^b   Ottenhoff, Tom H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; FC RECEPTOR; PATTERN RECOGNITION RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; FIBROSIS; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; INFLAMMATION; MONOCYTE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUBERCULOSIS;

BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; SIGNAL TRANSDUCTION; TUBERCULOSIS;

EID: 84884179172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073230     Document Type: Article

References (58)

1. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69: 89-95.
2. Ottenhoff TH, Ellner JJ, Kaufmann SH, (2012) Ten challenges for TB biomarkers. Tuberculosis (Edinb) 92Suppl 1: S17-S20.
3. World Health Organization (2004) Global Tuberculosis Control. WHO report, WHO, Geneva.
4. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, et al. (2013) The immune response in tuberculosis. Annu Rev Immunol 31: 475-527.
5. Ottenhoff TH, Kaufmann SH, (2012) Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 8: e1002607.
6. Kagina BM, Abel B, Scriba TJ, Hughes EJ, Keyser A, et al. (2010) Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns. Am J Respir Crit Care Med 182: 1073-1079.
7. Lienhardt C, Sillah J, Fielding K, Donkor S, Manneh K, et al. (2003) Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa. Pediatrics 111: e608-e614.
8. Dockrell HM, Smith SG, Lalor MK, (2012) Variability between countries in cytokine responses to BCG vaccination: what impact might this have on protection? Expert Rev Vaccines 11: 121-124.
9. Lalor MK, Smith SG, Floyd S, Gorak-Stolinska P, Weir RE, et al. (2010) Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine 28: 1635-1641.
10. Sell H, Habich C, Eckel J, (2012) Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 8: 709-716.
11. Harford KA, Reynolds CM, McGillicuddy FC, Roche HM, (2011) Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc Nutr Soc 70: 408-417.
12. World Health Organization (2011) Collaborative Framework for Care and Control of Tuberculosis and Diabetes. Available: http://whqlibdoc who int/publications/2011/9789241502252_eng pdf.
13. Maurice J, (2011) WHO framework targets tuberculosis-diabetes link. Lancet 378: 1209-1210.
14. Dye C, Bourdin TB, Lonnroth K, Roglic G, Williams BG, (2011) Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS One 6: e21161.
15. Sullivan T, Ben AY, (2012) The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world. PLoS Med 9: e1001269.
16. Dai G, Phalen S, McMurray DN, (1998) Nutritional modulation of host responses to mycobacteria. Front Biosci 3: e110-e122.
17. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
18. Maertzdorf J, Ota M, Repsilber D, Mollenkopf HJ, Weiner J, et al. (2011) Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One 6: e26938.
19. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, et al. (2011) Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12: 15-22.
20. Mistry R, Cliff JM, Clayton CL, Beyers N, Mohamed YS, et al. (2007) Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis 195: 357-365.
21. Hanekom WA, (2005) The immune response to BCG vaccination of newborns. Ann N Y Acad Sci 1062: 69-78.
22. Smith SG, Joosten SA, Verscheure V, Pathan AA, McShane H, et al. (2009) Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One 4: e7972.
23. McKenna KC, Beatty KM, Vicetti MR, Bilonick RA, (2009) Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function. J Immunol Methods 341: 68-75.
24. Britten CM, Janetzki S, Butterfield LH, Ferrari G, Gouttefangeas C, et al. (2012) T cell assays and MIATA: the essential minimum for maximum impact. Immunity 37: 1-2.
25. Hanekom WA, Hughes J, Mavinkurve M, Mendillo M, Watkins M, et al. (2004) Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods 291: 185-195.
26. Maertzdorf J, Weiner J III, Mollenkopf HJ, Bauer T, Prasse A, et al. (2012) Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A 109: 7853-7858.
27. Koh GC, Schreiber MF, Bautista R, Maude RR, Dunachie S, et al. (2013) Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling. PLoS One 8: e54961.
28. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, et al. (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10: 116-125.
29. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med (Berl) 85: 613-621.
30. Joosten SA, Goeman JJ, Sutherland JS, Opmeer L, de Boer KG,et al. (12 A.D.) Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes Immun 13: 71-82.
31. Cliff JM, Lee JS, Constantinou N, Cho JE, Clark TG, et al. (2013) Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 207: 18-29.
32. Ottenhoff TH, Dass RH, Yang N, Zhang MM, Wong HE, et al. (2012) Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS One 7: e45839.
33. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, et al. (2008) A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29: 150-164.
34. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
35. Gomez-Pina V, Soares-Schanoski A, Rodriguez-Rojas A, Del FC, Garcia F, et al. (2007) Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 179: 4065-4073.
36. Ford JW, McVicar DW, (2009) TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 21: 38-46.
37. Arts RJ, Joosten LA, van der Meer JW, Netea MG, (2013) TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol 93: 209-215.
38. Tintinger GR, van der Merwe JJ, Fickl H, Rheeder P, Feldman C, et al. (2012) Soluble triggering receptor expressed on myeloid cells in sputum of patients with community-acquired pneumonia or pulmonary tuberculosis: a pilot study. Eur J Clin Microbiol Infect Dis 31: 73-76.
39. Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-Gonzalez A, et al. (2009) Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 34: 1383-1389.
40. Chan MC, Chang KM, Chao WC, Lin LY, Kuo BI, et al. (2007) Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. Respirology 12: 333-338.
41. Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L, et al. (2004) Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 24: 247-250.
42. Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, et al. (2007) Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 67: 10703-10710.
43. Ulrichs T, Kosmiadi GA, Trusov V, Jorg S, Pradl L, et al. (2004) Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J Pathol 204: 217-228.
44. Phuah JY, Mattila JT, Lin PL, Flynn JL, (2012) Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis. Am J Pathol 181: 508-514.
45. Maglione PJ, Chan J, (2009) How B cells shape the immune response against Mycobacterium tuberculosis. Eur J Immunol 39: 676-686.
46. McEwan WA, Tam JC, Watkinson RE, Bidgood SR, Mallery DL, et al. (2013) Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat Immunol 14: 327-336.
47. Geijtenbeek TB, Gringhuis SI, (2013) An inside job for antibodies: tagging pathogens for intracellular sensing. Nat Immunol 14: 309-311.
48. Das B, Kashino SS, Pulu I, Kalita D, Swami V, et al. (2013) CD271+ Bone Marrow Mesenchymal Stem Cells May Provide a Niche for Dormant Mycobacterium tuberculosis. Sci Transl Med 5: 170ra13.
49. Masaki T, Qu J, Cholewa-Waclaw J, Burr K, Raaum R, et al. (2013) Reprogramming Adult Schwann Cells to Stem Cell-like Cells by Leprosy Bacilli Promotes Dissemination of Infection. Cell 152: 51-67.
50. Teles RM, Graeber TG, Krutzik SR, Montoya D, Schenk M, et al. (2013) Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339: 1448-1453.
51. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, et al. (2013) Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340: 202-207.
52. Decker T, Muller M, Stockinger S, (2005) The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 5: 675-687.
53. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, et al. (2001) Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci U S A 98: 5752-5757.
54. Bouchonnet F, Boechat N, Bonay M, Hance AJ, (2002) Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG. Infect Immun 70: 3020-3025.
55. Markey MP, Bergseid J, Bosco EE, Stengel K, Xu H, et al. (2007) Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function. Oncogene 26: 6307-6318.
56. Elkington PT, Ugarte-Gil CA, Friedland JS, (2011) Matrix metalloproteinases in tuberculosis. Eur Respir J 38: 456-464.
57. Hrabec E, Strek M, Zieba M, Kwiatkowska S, Hrabec Z, (2002) Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int J Tuberc Lung Dis 6: 713-719.
58. Starr AE, Bellac CL, Dufour A, Goebeler V, Overall CM, (2012) Biochemical characterization and N-terminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities. J Biol Chem 287: 13382-13395.